Hao WR, Cheng CH, Cheng TH. Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men. World J Cardiol 2024; 16(9): 502-507 [DOI: 10.4330/wjc.v16.i9.502]
Corresponding Author of This Article
Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. [email protected]
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Sep 26, 2024; 16(9): 502-507 Published online Sep 26, 2024. doi: 10.4330/wjc.v16.i9.502
Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men
Wen-Rui Hao, Chun-Han Cheng, Tzu-Hurng Cheng
Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei 23561, Taiwan
Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11002, Taiwan
Chun-Han Cheng, Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan
Tzu-Hurng Cheng, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung 404328, Taiwan
Author contributions: Hao WR and Cheng CH primarily responsible for writing; Cheng TH overseeing revisions; all authors have read and approved the final manuscript.
Conflict-of-interest statement: All authors declare having no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. [email protected]
Received: July 5, 2024 Revised: August 21, 2024 Accepted: September 5, 2024 Published online: September 26, 2024 Processing time: 75 Days and 15.3 Hours
Abstract
This editorial discusses the key findings presented in Batta and Hatwal’s recent paper titled “Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!”, which was published in the World Journal of Cardiology. Their original article highlights a notable correlation between nonalcoholic fatty liver disease (NAFLD) and increased cardiovascular mortality risk in men. The present commentary explores the implications of their findings, discussing potential mechanisms, risk factors, and the urgent need for integrated clinical approaches to mitigate the dual burden of these diseases. Emphasis should be placed on the importance of early detection, lifestyle modifications, and interdisciplinary collaboration for improving patient outcomes. This editorial aims to highlight the broad implications of NAFLD for cardiovascular health and to advocate for increased awareness and proactive management strategies within the medical community.
Core Tip: Men with nonalcoholic fatty liver disease (NAFLD) have a significantly increased risk of cardiovascular mortality, which is a major health concern. Early detection and comprehensive management strategies targeting both NAFLD and cardiovascular risk factors are essential to mitigate excess mortality.
